Results 41 to 50 of about 17,267 (217)

Prosthetic and native valve endocarditis.

, 2015
PVE—prosthetic valve endocarditis; NVE—native valve endocarditis; N—number; p—p value; NS—non significant.Prosthetic and native valve endocarditis.
Elżbieta Abramczuk (778050), Tomasz Hryniewiecki (563280), Janina Stępińska (778051)   +2 more
core   +1 more source

Prosthetic Valve Candida Endocarditis: A Case Report with 18F-FDG-PET/CT as Part of the Diagnostic Workup

Case Reports in Cardiology, 2020
Diagnosis of Candida spp. infective endocarditis (IE) is challenging, and diagnostic delays are common. We describe two patients with Candida spp.
Soile Pauliina Salomäki, Antti Saraste, Päivi Jalava-Karvinen, Laura Pirilä, Ulla Hohenthal   +4 more
doaj   +1 more source

Fungal prosthetic endocarditis presenting as intracranial hemorrhage

Indian Journal of Pathology and Microbiology
Fungal endocarditis is a rare infection of the heart valve, forming less than 3% of infective endocarditis. Prosthetic valves have a higher rate of infection in the initial three months of surgery. Among the prosthetic valve endocarditis, fungal etiology
Tapamita Gupta, Krishnendu Das, Kiran Bhagwat, Manoj Gopal Madakshira   +3 more
doaj   +1 more source

Recurrent prosthetic valve endocarditis caused by Aspergillus delacroxii (formerly Aspergillus nidulans var. echinulatus)

Medical Mycology Case Reports, 2015
We report Aspergillus delacroxii (formerly Aspergillus nidulans var. echinulatus) causing recurrent prosthetic valve endocarditis. The fungus was the sole agent detected during replacement of a mechanical aortic valve conduit due to abscess formation ...
Gábor Balázs Uhrin, Rasmus Hare Jensen, Eva Korup, Jens Grønlund, Ulla Hjort, Claus Moser, Maiken Cavling Arendrup, Henrik Carl Schønheyder   +7 more
doaj   +1 more source

Clinical and Echocardiographic Outcomes After Implantation of the ALLEGRA Transcatheter Valve Using the Fully Repositionable IMPERIA Delivery System: One‐Year Results of the EMPIRE I Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz, Claire B. Ren, Christof Burgdorf, Christian Frerker, Ignacio Cruz‐González, Joan Antoni Gómez, José Maria Hernândez, Pilar Jimenez, Ernest Spitzer, Pim Tonino, Pieter Vriesendorp, Nicolas van Mieghem, Samuel Copt, Anders Jönsson, Keith G. Oldroyd, Nicolas Doll   +15 more
wiley   +1 more source

Estudio de las complicaciones perianulares en la endocarditis infecciosa. Análisis de aspectos clínicos, microbiológicos, ecocardiográficos, terapéuticos y pronósticos en pacientes con abscesos perianulares y fístulas aorto-cavitarias en la endocarditis complicada. [PDF]

, 2006
[spa] La endocarditis infecciosa (EI) es una enfermedad potencialmente muy grave, que puede llegar a ser mortal sin tratamiento, cuyo pronóstico ha experimentado una gran mejoría en las ultimas décadas. Este importante cambio en la historia natural de la
Anguera Camós, Ignasi
core  

Corynebacterium striatum prosthetic valve endocarditis. A case report and literature review

Clinical Infection in Practice, 2020
Background: Corynebacterium striatum is a Gram-positive bacillus. It is one of the normal commensal flora of the skin and mucous membranes. It is generally considered to be a contaminant when grown in blood culture, however, it is increasingly recognized
Mohamed Kamal Mansour, Ahmed Hussain Al-Messabi, Sundos Abdulla Ahmed, Fouzia Jabeen, Ibrahim Salah Moumne, Emmanuel Fru Nsutebu   +5 more
doaj   +1 more source

Aortic valve replacement after previous TAVI

Вестник трансплантологии и искусственных органов, 2023
Endovascular surgery for aortic valve defects has proven itself well in elderly patients with severe comorbidities competing with the underlying disease. However, the risk of dysfunction resulting from structural degeneration of bioprosthetic heart valve
D. A. Titov, M. N. Sorkomov, D. M. Pursanova, M. I. Fedoseykina, S. I. Babenko, R. M. Muratov   +5 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Contemporary clinical profile and outcome of prosthetic valve endocarditis

, 2007
CONTEXT: Prosthetic valve endocarditis (PVE) is associated with significant mortality and morbidity. The contemporary clinical profile and outcome of PVE are not well defined.
Rizzi, Marco, Corey, G. Ralph, Iarussi, Diana L, Tattevin, Pierre, Logar, Mateja, Casabé, José, Fowler, Vance G., Jr., Selton-Suty, Christine, Jones, Sandra Braun, Pappas, Paul A, Cabell, Christopher H., Paré, Carlos, Iarussi, Diana L., Selton Suty, Christine, Pappas, Paul A., Muñoz, Patricia, Wang, Andrew, Olaison, Lars, Almirante, Benito, Fowler, Vance G, Athan, Eugene, Corey, G Ralph, Cabell, Christopher H, Morris, Arthur, Naber, Christoph, Olaison, Lars,   +25 more
core   +1 more source